Africa Centers for Disease Control ...s="attribute-to-highlight medbox">and Prevention (Africa CDC) está ciente dos comunicados de imprensa sobre os resultados preliminares de um grande ensaio clínico aleatório realizado no Reino Unido, que incluía dexametasona, um corticosteróide, como um dos medicamentos utilizados para o tratamento de doentes com COVID-19. Os investigadores relataram que a administração de dexametasona oral ou injectável resultou numa redução de cerca de um terço na mortalidade entre os doentes com COVID-19 que necessitavam de ventilação mecânica e cerca de um quinto para os doentes que necessitavam de oxigénio. Desde a publicação destes relatórios nos meios de comunicação social, as autoridades sanitárias do Reino Unido e da África do Sul adoptaram a dexametasona para o tratamento de doentes com formas graves de COVID-19
more
O Centro Africano de Prevenção e Luta contra Doenças (CDC-África) está preocupado com a divulgação de informações incorrectas através de meios de comunicação tradicionais e sociais sobre... a prevenção e o tratamento de nova doença de coronavírus (COVID-19).
more
Accessed: 31.03.2020
French:
ÉTATS MEMBRES DE L’UNION AFRICAINE NUMÉROS D’URGENCE DE LA COVID-19 (HOTLINES) - Centres africains de prévention et de ...box">contrôle des maladies
Arabic:
أرقام الطوارئ المخصصة للكوفيد-١٩ في الدول الأعضاء في) الاتحاد الأفريقي (الخطوط الساخنة)
more
This document draws on scientific evidence from the COVID-19 pandemic and from prior public health research on behaviour change, with the purpose of empowering African Union Member States to promote widespread adoption of masks in the general popula...tion. This document complements existing Africa CDC technical guidance on the community use of face masks.
more
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID...-19 to review existing data and evidence and recommend
more
This guidance document addresses how physical distancing (referred to in previous guidance documents as ‘social distancing’) can help slow down transmission.
ASLM in collaboration with the Africa Centres for Disease ...dbox">Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to provide general technical guidance to African Union Members States on the rollout, establishment, implementation, monitoring, and evaluation of SARS-CoV-2 Ag RDT interventions so as to effectively and efficiently detect, control and minimise errors in the performance of COVID-19 laboratory testing processes. It describes the core components for quality assurance, resources mobilisation and advocacy for scale up, monitoring, evaluation, learning and accountability for SARS-CoV-2 implementation.
more
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control ... class="attribute-to-highlight medbox">and accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
more
Key findings from a February 2021 survey from the Partnership for Evidence-Based Response to COVID-19 (PERC)
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control ... class="attribute-to-highlight medbox">and accountability of biological materials and information related to these materials and dualuse research, to prevent their unauthorized access, loss, theft, misuse, diversion or intentional release.
more
L’ivermectine est un médicament antiparasitaire approuvé pour le traitement des infections parasitaires, y compris la strongyloïdose et l’onchocercose, chez l’être humain. Récemment, on a indiqué une augmentation de l’utilisation de l’ivermectine pour la ...hlight medbox">prévention et le traitement de la COVID-19 par le public dans les États membres de l’Union africaine. Actuellement, il n’y a : 1. Aucune preuve scientifique provenant d’études précliniques sur l’effet thérapeutique de l’ivermectine pour le traitement de COVID-19 2. Aucune preuve de son efficacité clinique pour la prise en charge de patients présentant une COVID-19 asymptomatique, légère, modérée ou sévère 3. Aucune donnée de sécurité concernant l’utilisation de l’ivermectine pour la COVID-19 dans la majorité des études publié
more
Since the emergence of COVID 19 in December 2019, various public health responses measures have been implemented to control the pandemic. Among measures taken by the Africa ...-highlight medbox">CDC was the launch of PACT initiative to accelerate COVID 19 testing. Key to the initiative is the engagement of Community Health Workers (CHWs) in risk communication and community engagement (RCCE), surveillance activities for early case identification, contacts tracing and in facilitating referrals for testing and continuum of care.
As of 31 May 2021, Through PACT support, over 17154 CHWs have been trained and locally deployed in 24 AU Member states. The PACT supported CHWs visited more than 2,568,654 households for community engagement activities, active case search and contact tracing, identified 1,618,601 Contacts, 710,167 COVID 19 suspect cases based on the standard case definition and facilitated referrals for 553053 (78%) suspect cases for testing. These efforts were crucial for early identification and isolation of cases in limiting further transmission.
more